JOHNSON DAVID LEE (Chief Commercial Officer) received a stock award from GLOBAL BLOOD THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/6/2022ACC: 0000899243-22-030479
Officer· Chief Commercial Officer
Since Feb 2019
-1.74K
Net shares
Net seller
$143.3K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
5.34K acquired · 7.07K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+365.00
Price / share
$25.37
Trade value
$9.26K
% of position
0.7%
8/31/2022
53.15K→53.52K
Common Stock
Direct
Shares
+2.76K
Price / share
—
Trade value
—
% of position
5.2%
9/1/2022
53.52K→56.28K
Common Stock
Direct
Shares
+2.21K
Price / share
—
Trade value
—
% of position
3.9%
9/1/2022
56.28K→58.49K
Common Stock
Direct
Shares
−2.10K
Price / share
$68.15
Trade value
$143.32K
% of position
3.6%
9/1/2022
58.49K→56.38K
Total
Net shares
+3.23K
Net value
-$134.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2022 | A · Award | +365.00 | $25.37 | $9.26K | 0.7% | 53.15K | 53.52K |
| Common Stock Direct | 9/1/2022 | M · Option Exercise | +2.76K | — | — | 5.2% | 53.52K | 56.28K |
| Common Stock Direct | 9/1/2022 | M · Option Exercise | +2.21K | — | — | 3.9% | 56.28K | 58.49K |
| Common Stock Direct | 9/1/2022 | F · Tax Withholding | −2.10K | $68.15 | $143.32K | 3.6% | 58.49K | 56.38K |
| Total | +3.23K | -$134.06K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
2.76K shares
Shares
−2.76K
Strike price
Held after
13.81K
Exercisable
—
9/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
2.21K shares
Shares
−2.21K
Strike price
Held after
15.46K
Exercisable
—
9/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.76K shares | 9/1/2022 | M · Option Exercise | −2.76K | — | 13.81K | |
| Restricted Stock Units Direct | Common Stock2.21K shares | 9/1/2022 | M · Option Exercise | −2.21K | — | 15.46K |